n South African Medical Journal - Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, Ben Goldacre : book review - izindaba

Volume 103, Issue 6
  • ISSN : 0256-9574
  • E-ISSN: 2078-5135



For a new medicine or vaccine to make a meaningful contribution to the prevention and/or treatment of disease, it has to clear a number of hurdles: consistent evidence of efficacy, in the population to be treated; safety, insofar as the benefit of the medicine should justify the risk of possible adverse events; and quality, demonstrated by laboratory studies. All this, it is generally assumed, derives from studies conducted ethically, objectively and honestly by clinical and pharmaceutical scientists.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error